Pharmaceutical Care for a Case of Pan-drug Resistant Acinetobacter baumannii Pulmonary Infection / 中国药房
China Pharmacy
;
(12): 3726-3728, 2015.
Artículo
en Chino
| WPRIM
| ID: wpr-502645
ABSTRACT
OBJECTIVE:
To explore the role of clinical pharmacists in the treatment of pan-drug resistant Acinetobacter bau-mannii infection.METHODS:
Clinical pharmacists participated in the treatment for a severe pneumonia case of pan-drug resistant A. baumannii infection. Clinical pharmacists supplied overall pharmaceutical care and suggestions with respects to initial medication scheme evaluation,pathogen judgment,therapy drug selection,ADR disposal,etc.,including anti-infective treatment of moxifloxa-cin 0.4 g,ivgtt,qd+meropenem 0.5 g,ivgtt,q8 h+linezolid 0.6 g,ivgtt,q12 h;anti-pan-drug resistant A. baumannii infection of cefoperazone sodium and sulbactam sodium 3.0 g,ivgtt,q8 h+tigecycline 50 mg,ivgtt,q12 h;liver protection of ademetionine 1, 4-Butanedisulfonate 1.0 g,ivgtt,qd+reduced glutathione 1.8 g,ivgtt,qd.RESULTS:
After 25 d treatment,the patient hadn’t been fe-vered,and hemogram and hepatic function index decreased to normal value.CONCLUSIONS:
Clinical pharmacist should be en-gage in anti-infective treatment and pharmaceutical care,and provide physicians reasonable medication suggestion so as to promote care rate in the clinic.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
China Pharmacy
Año:
2015
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS